Panacea Biotec Limited (NSE:PANACEABIO)
India · Delayed Price · Currency is INR 544.00
-2.60 (-0.48%)
Jul 13, 2026, 3:30 PM IST
Panacea Biotec Market Cap
Panacea Biotec has a market cap or net worth of 33.23 billion as of July 13, 2026. Its market cap has increased by 27.33% in one year.
Market Cap
33.23B
Enterprise Value
32.06B
Revenue
6.40B
Ranking
n/a
PE Ratio
n/a
Stock Price
544.00
Market Cap Chart
Since April 1, 2002, Panacea Biotec's market cap has increased from 21.08B to 33.23B, an increase of 57.66%. That is a compound annual growth rate of 1.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 33.23B | 44.17% |
| Dec 31, 2025 | 23.05B | -10.11% |
| Dec 31, 2024 | 25.64B | 149.32% |
| Dec 29, 2023 | 10.28B | 18.20% |
| Dec 30, 2022 | 8.70B | -28.49% |
| Dec 31, 2021 | 12.17B | -17.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 653.09B |
| Anthem Biosciences | 423.52B |
| OneSource Specialty Pharma | 186.52B |
| Concord Biotech | 136.49B |
| Blue Jet Healthcare | 108.25B |
| Supriya Lifescience | 68.78B |
| Zota Health Care | 49.10B |
| Dishman Carbogen Amcis | 30.71B |